Demethylation and epigenetic modification with 5-azacytidine reduces IDH1 mutant glioma growth in combination with temozolomide.

MLA

Yamashita, Alex Shimura, et al. “Demethylation and Epigenetic Modification with 5-Azacytidine Reduces IDH1 Mutant Glioma Growth in Combination with Temozolomide.” Neuro-Oncology, vol. 21, no. 2, Feb. 2019, pp. 189–200. EBSCOhost, https://doi.org/10.1093/neuonc/noy146.

APA

Yamashita, A. S., da Costa Rosa, M., Borodovsky, A., Festuccia, W. T., Chan, T., & Riggins, G. J. (2019). Demethylation and epigenetic modification with 5-azacytidine reduces IDH1 mutant glioma growth in combination with temozolomide. Neuro-Oncology, 21(2), 189–200. https://doi.org/10.1093/neuonc/noy146

Chicago

Yamashita, Alex Shimura, Marina da Costa Rosa, Alexandra Borodovsky, William T Festuccia, Timothy Chan, and Gregory J Riggins. 2019. “Demethylation and Epigenetic Modification with 5-Azacytidine Reduces IDH1 Mutant Glioma Growth in Combination with Temozolomide.” Neuro-Oncology 21 (2): 189–200. doi:10.1093/neuonc/noy146.